Skip to content
Delayed ~15 min

ASPN ASPEN AEROGELS

Consumer Discretionary · Russell 2000

Next earnings: not announced yet

What 8 analyst firms say about ASPEN AEROGELS: their latest ratings, price targets and how far the stock is from them. How it works

4.91 USD−0.25 (−4.85%) today
Price as of 6 Nov 16:00 ET

Analyst window: Latest analyst report within last 1 year

Analyst view · last 1Y

+49.7%to the avg target 7.35 USD+2.44 USD
Buy 5 · Hold 1 · Sell 1

7 rated views · 8 analyst/firm records · 8 firms

Latest report11 Aug 2026avg report date 14 Jun
Target rangePrice is below every target

Radar score

  • Russell 2000 · Top Picks · 6MNot scored · Price below 5 USD
  • Russell 2000 · Safest consensus · 6MNot scored · Price below 5 USD

Recent analyst activity · last 90 days

Our tracked history has 2 reports on ASPN from 2 analyst firms in the last 90 days (8 firms in the past year).

Comparing each firm's latest target with its previous one: 1 raised its price target.

No firm's latest available rating differs from its previous one.

Latest observed target change: Barclays raised its target from $4.00 (set 11 May 2026) to $5.00 on 11 Aug 2026.

Last 1 year. Latest opinion per identifiable analyst within the last 1 year. BUY / HOLD / SELL each count one current analyst vote; unnamed firm records are a fallback.

FirmAnalystLatest ratingReport dateLatest target (USD)
B Riley SecuritiesRyan J PfingstBuy7 Aug 20269.00 USD
BarclaysDavid AndersonSell11 Aug 20265.00 USD
Canaccord GenuityGeorge GianarikasBuy7 Nov 20255.00 USD
Craig-HallumEric A StineBuy6 Aug 202610.00 USD
Roth CapitalChip MooreBuy7 Aug 20267.75 USD
TD CowenItay MichaeliBuy26 Feb 2026Conflicting reports · excluded
Weiss RatingsUnnamed analyst—21 Sep 2026—
Data feed RESEARCHResearch TeamHold15 Jan 2026—

Partial coverage · checked 6 Nov (6 Nov 2026, 06:59 ET). Some research records could not be refreshed. Cached records retained. Prices stream live during the US session; otherwise stored prices delayed about 15 minutes. A summary of analyst opinion, not investment advice.